Clinical Trial Evaluating Safety of 5-Aminolevulinic Acid (5-ALA) Combined With CV01 Delivery of Ultrasound for Sonodynamic Therapy (SDT) in Patients With Newly Diagnosed High-Grade Glioma (HGG) Prior to Resection and Standard Adjuvant Therapy (ALA SDT GLIOMA 401)
Phase 1 Completed
16 enrolled
INCB7839 in Treating Children With Recurrent/Progressive High-Grade Gliomas
Phase 1 Completed
13 enrolled 15 charts
Alisertib and Fractionated Stereotactic Radiosurgery in Treating Patients With Recurrent High Grade Gliomas
Phase 1 Completed
17 enrolled 11 charts
Neo-adjuvant Evaluation of Glioma Lysate Vaccines in WHO Grade II Glioma
Phase 1 Completed
28 enrolled
Lapatinib Ditosylate Before Surgery in Treating Patients With Recurrent High-Grade Glioma
Phase 1 Completed
29 enrolled
SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors
Phase 1 Completed
68 enrolled
Phase 1b Study PVSRIPO for Recurrent Malignant Glioma in Children
Phase 1 Completed
8 enrolled 9 charts
Liposomal Doxorubicin in Treating Children With Refractory Solid Tumors
Phase 1 Completed
HSV G207 Alone or With a Single Radiation Dose in Children With Progressive or Recurrent Supratentorial Brain Tumors
Phase 1 Completed
13 enrolled
Stereotactic Radiosurgery in Treating Patients With Brain Tumors
Phase 1 Completed
Perifosine and Torisel (Temsirolimus) for Recurrent/Progressive Malignant Gliomas
Phase 1 Completed
10 enrolled
Wild-Type Reovirus in Combination With Sargramostim in Treating Younger Patients With High-Grade Relapsed or Refractory Brain Tumors
Phase 1 Completed
6 enrolled
Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors
Phase 1 Completed
16 enrolled
G-FORCE-1
Phase 1 Completed
19 enrolled
Safety Study of Afatinib for Brain Cancer
Phase 1 Completed
24 enrolled
Genetically Modified Neural Stem Cells, Flucytosine, and Leucovorin for Treating Patients With Recurrent High-Grade Gliomas
Phase 1 Completed
16 enrolled 16 charts
Vaccine Therapy in Treating Patients With Malignant Glioma
Phase 1 Completed
28 enrolled
Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma
Phase 1 Completed
19 enrolled
Sodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other Cancers
Phase 1 Completed
22 enrolled
Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors
Phase 1 Completed
21 enrolled
Viral Therapy in Treating Patients With Recurrent Glioblastoma Multiforme
Phase 1 Completed
23 enrolled 15 charts
AZD8055 for Adults With Recurrent Gliomas
Phase 1 Completed
22 enrolled
Hypofractionated Stereotactic Radiotherapy With Bevacizumab in the Treatment of Recurrent Malignant Glioma
Phase 1 Completed
15 enrolled
Dexanabinol in Patients With Brain Cancer
Phase 1 Completed
26 enrolled
Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma
Phase 1 Completed
28 enrolled
Photodynamic Therapy (PDT) for Recurrent Pediatric Brain Tumors
Phase 1 Completed
5 enrolled
Carboplatin in Treating Patients With Recurrent High-Grade Gliomas
Phase 1 Completed
10 enrolled
Tumor Tissue Analysis in Patients Receiving Imatinib Mesylate for Malignant Glioma
Phase 1 Completed
3 enrolled
Gene Therapy in Treating Patients With Recurrent Malignant Gliomas
Phase 1 Completed
Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma
Phase 1 Completed
Gefitinib Plus Temozolomide in Treating Patients With Malignant Primary Glioma
Phase 1 Completed
A Study of a Retroviral Replicating Vector Combined With a Prodrug Administered to Patients With Recurrent Malignant Glioma
Phase 1 Completed
54 enrolled
Study of a Retroviral Replicating Vector Combined With a Prodrug to Treat Patients Undergoing Surgery for a Recurrent Malignant Brain Tumor
Phase 1 Completed
58 enrolled
Study of a Retroviral Replicating Vector Given Intravenously to Patients Undergoing Surgery for Recurrent Brain Tumor
Phase 1 Completed
17 enrolled
A Feasibility, Dose-Escalation Study Using Intracerebral Microdialysis to Assess the Neuropharmacodynamics of Temsirolimus in Patients With Primary or Metastatic Brain Tumors
Phase 1 Completed
12 enrolled
Bafetinib in Treating Patients With Recurrent High-Grade Glioma or Brain Metastases
Phase 1 Completed
7 enrolled
A Pilot Feasibility Study of Oral 5-Fluorocytosine and Genetically-Modified Neural Stem Cells Expressing E.Coli Cytosine Deaminase for Treatment of Recurrent High Grade Gliomas
Phase 1 Completed
15 enrolled
Cellular Adoptive Immunotherapy Using Genetically Modified T-Lymphocytes in Treating Patients With Recurrent or Refractory High-Grade Malignant Glioma
Phase 1 Completed
3 enrolled
p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors
Phase 1 Completed
18 enrolled
Vaccine Therapy and Sargramostim in Treating Patients With Malignant Glioma
Phase 1 Completed
9 enrolled
alloCTL
Phase 1 Completed
10 enrolled
AZD2171 in Treating Young Patients With Recurrent, Progressive, or Refractory Primary CNS Tumors
Phase 1 Completed
55 enrolled
Imatinib Mesylate, Vatalanib, and Hydroxyurea in Treating Patients With Recurrent or Relapsed Malignant Glioma
Phase 1 Completed
37 enrolled
Vaccine Therapy in Treating Patients With Malignant Glioma
Phase 1 Completed
8 enrolled
RO4929097, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Malignant Glioma
Phase 1 Completed
22 enrolled
PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors
Phase 1 Completed
28 enrolled
CC-5013 in Treating Patients With Recurrent Glioma
Phase 1 Completed
CC-8490 in Treating Patients With Recurrent or Refractory High-Grade Gliomas
Phase 1 Completed
Temozolomide and O6-benzylguanine in Treating Children With Solid Tumors
Phase 1 Completed
Radiolabeled Monoclonal Antibody Therapy After Radiation Therapy in Treating Patients With Primary Brain Tumors
Phase 1 Completed
21 enrolled